1. Home
  2. STOK vs MITK Comparison

STOK vs MITK Comparison

Compare STOK & MITK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • MITK
  • Stock Information
  • Founded
  • STOK 2014
  • MITK 1983
  • Country
  • STOK United States
  • MITK United States
  • Employees
  • STOK N/A
  • MITK N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • MITK Computer peripheral equipment
  • Sector
  • STOK Health Care
  • MITK Technology
  • Exchange
  • STOK Nasdaq
  • MITK Nasdaq
  • Market Cap
  • STOK 379.6M
  • MITK 411.7M
  • IPO Year
  • STOK 2019
  • MITK N/A
  • Fundamental
  • Price
  • STOK $7.69
  • MITK $7.65
  • Analyst Decision
  • STOK Strong Buy
  • MITK Strong Buy
  • Analyst Count
  • STOK 6
  • MITK 4
  • Target Price
  • STOK $26.00
  • MITK $12.88
  • AVG Volume (30 Days)
  • STOK 987.9K
  • MITK 474.2K
  • Earning Date
  • STOK 05-05-2025
  • MITK 05-09-2025
  • Dividend Yield
  • STOK N/A
  • MITK N/A
  • EPS Growth
  • STOK N/A
  • MITK N/A
  • EPS
  • STOK N/A
  • MITK 0.10
  • Revenue
  • STOK $36,555,000.00
  • MITK $172,420,000.00
  • Revenue This Year
  • STOK $27.80
  • MITK $4.03
  • Revenue Next Year
  • STOK $9.53
  • MITK $8.97
  • P/E Ratio
  • STOK N/A
  • MITK $79.41
  • Revenue Growth
  • STOK 316.34
  • MITK 5.28
  • 52 Week Low
  • STOK $5.35
  • MITK $6.93
  • 52 Week High
  • STOK $17.58
  • MITK $14.32
  • Technical
  • Relative Strength Index (RSI)
  • STOK 53.59
  • MITK 38.24
  • Support Level
  • STOK $7.31
  • MITK $7.46
  • Resistance Level
  • STOK $7.99
  • MITK $7.94
  • Average True Range (ATR)
  • STOK 0.61
  • MITK 0.38
  • MACD
  • STOK 0.23
  • MITK 0.03
  • Stochastic Oscillator
  • STOK 88.64
  • MITK 47.06

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About MITK Mitek Systems Inc.

Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.

Share on Social Networks: